{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:33:56Z","timestamp":1789011236817,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:00:00Z","timestamp":1513555200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10067-017-3954-5","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:05:54Z","timestamp":1513555554000},"page":"1709-1714","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3703-1268","authenticated-orcid":false,"given":"Grzegorz","family":"Helbig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Widuchowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kocl\u0119ga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kopi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kope\u0107-M\u0119drek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W\u0142adys\u0142aw B.","family":"Gawe\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianna","family":"Spa\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"\u017bak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Grygoruk-Wi\u015bniowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Liwoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugeniusz","family":"Kucharz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miros\u0142aw","family":"Markiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,18]]},"reference":[{"issue":"19","key":"3954_CR1","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento E, Krieg T (2009) Mechanisms of disease: scleroderma. N Engl J Med 360(19):1989\u20132003. \nhttps:\/\/doi.org\/10.1056\/NEJMra0806188","journal-title":"N Engl J Med"},{"issue":"8","key":"3954_CR2","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"MD Mayes","year":"2003","unstructured":"Mayes MD, Lacey JVJ, Beebe-Dimmer J, Gillespie GW, Cooper B, Laing TJ et al (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48(8):2246\u20132255. \nhttps:\/\/doi.org\/10.1002\/art.11073","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3954_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/ard.2009.127621","volume":"70","author":"RT Domsic","year":"2011","unstructured":"Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA Jr (2011) Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis 70(1):104\u2013109. \nhttps:\/\/doi.org\/10.1136\/ard.2009.127621","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3954_CR4","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/art.38390","volume":"66","author":"SI Nihtyanova","year":"2014","unstructured":"Nihtyanova SI, Schreiber BE, Ong VH, Rosenberg D, Moinzadeh P, Coghlan JG, Wells AU, Denton CP (2014) Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol 66(6):1625\u20131635. \nhttps:\/\/doi.org\/10.1002\/art.38390","journal-title":"Arthritis Rheumatol"},{"issue":"2 Suppl 81","key":"3954_CR5","first-page":"156","volume":"32","author":"SI Nihtyanova","year":"2014","unstructured":"Nihtyanova SI, Ong VH, Denton CP (2014) Current management strategies for systemic sclerosis. Clin Exp Rheumatol 32(2 Suppl 81):156\u2013164","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"3954_CR6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/01.bor.0000434669.32150.ac","volume":"25","author":"JM Laar Van","year":"2013","unstructured":"Van Laar JM, Sullivan K (2013) Stem cell transplantation in systemic sclerosis. Curr Opin Rheumatol 25(6):719\u2013725. \nhttps:\/\/doi.org\/10.1097\/01.bor.0000434669.32150.ac","journal-title":"Curr Opin Rheumatol"},{"key":"3954_CR7","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","volume":"24","author":"JM Laar Van","year":"2014","unstructured":"Van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J et al (2014) Autologous hematopoietic stem cell transplantation vs intravenous cyclophosphamide in diffuse cutaneous systemic sclerosis. JAMA 24:2490\u20132498","journal-title":"JAMA"},{"issue":"9790","key":"3954_CR8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","volume":"378","author":"RK Burt","year":"2011","unstructured":"Burt RK, Shah SJ, Dill K, Grant T, Gheorghiade M, Schroeder J, Craig R, Hirano I, Marshall K, Ruderman E, Jovanovic B, Milanetti F, Jain S, Boyce K, Morgan A, Carr J, Barr W (2011) Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomized phase 2 trial. Lancet 378(9790):498\u2013506. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(11)60982-3","journal-title":"Lancet"},{"issue":"6","key":"3954_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/ard.60.6.577","volume":"60","author":"M Binks","year":"2001","unstructured":"Binks M, Passweg JR, Furst D, McSweeney P, Sullivan K, Besenthal C, Finke J, Peter HH, van Laar J, Breedveld FC, Fibbe WE, Farge D, Gluckman E, Locatelli F, Martini A, van den Hoogen F, van de Putte L, Schattenberg AV, Arnold R, Bacon PA, Emery P, Espigado I, Hertenstein B, Hiepe F, Kashyap A, K\u00f6tter I, Marmont A, Martinez A, Pascual MJ, Gratwohl A, Prentice HG, Black C, Tyndall A (2001) Phase I\/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis 60(6):577\u2013584. \nhttps:\/\/doi.org\/10.1136\/ard.60.6.577","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3954_CR10","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","volume":"110","author":"RA Nash","year":"2007","unstructured":"Nash RA, McSweeney PA, Crofford LJ, Abidi M, Chen CS, Godwin JD, Gooley TA, Holmberg L, Henstorf G, LeMaistre CF, Mayes MD, McDonagh KT, McLaughlin B, Molitor JA, Nelson JL, Shulman H, Storb R, Viganego F, Wener MH, Seibold JR, Sullivan KM, Furst d (2007) High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood 110(4):1388\u20131396. \nhttps:\/\/doi.org\/10.1182\/blood-2007-02-072389","journal-title":"Blood"},{"issue":"9872","key":"3954_CR11","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(12)62114-X","volume":"381","author":"RK Burt","year":"2013","unstructured":"Burt RK, Oliveira MC, Shah SJ, Moraes DA, Simoeas B, Gheorghiade M et al (2013) Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis. Lancet 381(9872):1116\u20131124. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(12)62114-X","journal-title":"Lancet"},{"issue":"4","key":"3954_CR12","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1183\/09031936.00091212","volume":"42","author":"BD Fox","year":"2013","unstructured":"Fox BD, Shimony A, Langleben D, Hirsch A, Rudski L, Schlesinger E et al (2013) High prevalence of occult left heart disease in scleroderma pulmonary hypertension. Eur Respir J 42(4):1083\u20131091. \nhttps:\/\/doi.org\/10.1183\/09031936.00091212","journal-title":"Eur Respir J"},{"issue":"2017","key":"3954_CR13","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/bmt.2017.56","volume":"52","author":"D Farge","year":"2017","unstructured":"Farge D, Burt RK, Oliveira MC, Mousseaux E, Rovira M, Marjanovic Z, de Vries-Bouwstra J, del Papa N, Saccardi R, Shah SJ, Lee DC, Denton C, Alexander T, Kiely DG, Snowden JA (2017) Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners. Bone Marrow Transplant 52(2017):1495\u20131503. \nhttps:\/\/doi.org\/10.1038\/bmt.2017.56\n\n. [epub ahead of print]","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"3954_CR14","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.semarthrit.2013.09.008","volume":"43","author":"M Hudson","year":"2014","unstructured":"Hudson M, Baron M, Tatibouet S, Furst DE, Khanna D (2014) Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis- results from the International Scleroderma Renal Crisis Survey. Semin Arthritis Rheum 43(5):666\u2013672. \nhttps:\/\/doi.org\/10.1016\/j.semarthrit.2013.09.008","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"3954_CR15","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1182\/blood-2011-02-336156","volume":"118","author":"Y Daikeler","year":"2011","unstructured":"Daikeler Y, Labopin M, Di Gioia M, Abinun M, Miniati I, Gualandi F et al (2011) Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of EBMT Autoimmune Disease Working Party. Blood 118(6):1693\u20131698. \nhttps:\/\/doi.org\/10.1182\/blood-2011-02-336156","journal-title":"Blood"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3954-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3954-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3954-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T03:03:37Z","timestamp":1526007817000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3954-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,18]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["3954"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3954-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,18]]}}}